A new study demonstrates that the combination of lenalidomide (Revlimid) and obinutuzumab (Gazyva) is effective and ...

Asunercept is under clinical development by Apogenix and currently in Phase I for Hematological Tumor. According to GlobalData, Phase I drugs for Hematological Tumor does not have sufficient ...

Tafasitamab is under clinical development by Incyte and currently in Phase II for Hematological Tumor. According to GlobalData, Phase II drugs for Hematological Tumor does not have sufficient ...

The correlation between ABO blood types and hematological myeloid neoplasms, however, remains inadequately explored. Objective: This study investigates the association between ABO blood groups and the ...

The following is a summary of “Impact of critical illness on continuation of anticancer treatment and prognosis of patients with aggressive hematological malignancies,” published in the September 2024 ...

Hematological indicators have been reported as being useful biomarkers for the prognosis of a variety of cancers. This study aimed to evaluate the feasibility of machine learning models characterized ...

Silence Therapeutics (SLNCF) targets cardiovascular and hematological diseases with RNA interference therapies. See why I ...

We now know why some blood is missing a key antigen—leading to the creation of a new blood-grouping system. Experts believe ...

Vallina, from the CRIS Immuno-Oncology Unit, in Madrid (Spain), explains that a new approach provides 'trained troops' of ...

[1] Anemia and its predictors among chronic kidney disease patients in Sub-Saharan African countries: A systematic review and meta-analysis ...

ICT01 showed tolerable safety and promising clinical activity as a monotherapy and is now being investigated in combination ...